Recon: US Patent Office to review Novo Nordisk semaglutide patent; WHO portal aims to simplify prequalification process

• Key Senate panel eyes action on drug shortages (STAT)
• Cancer drug shortage eases slightly, but it’s still ‘living from paycheck to paycheck’ (STAT)
• Was Amgen less than forthcoming about FDA’s concerns on its cancer drug? (STAT)
• Moderna’s plan to make a single vaccine for Covid, influenza, and RSV is on track (STAT)
• US Patent Office will review Novo Nordisk patent related to Wegovy, Ozempic (Reuters)
• US plans shift of Merck COVID treatment to commercial market (Reuters)
• 3 questions for the future of Biden’s cancer moonshot (STAT)
• FDA hands down partial clinical hold to Innate Pharma for cancer drug trials after patient death (Endpoints)
• FDA's oncology advisory committee backs potential high-risk neuroblastoma treatment (Endpoints)

• Novo Nordisk's Wegovy bonanza looms large in Denmark (Reuters)
• New ePortal To Simplify Processing & Tracking Of WHO Prequalification Applications (MedTech Insight)
• Lonza expands antibody-drug conjugate production pact, plots 180 new hires (Fierce Pharma)

• Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise (STAT)
• UniQure halves research, lays off 20% while CSO departs in major revamp (Endpoints)
• Gene therapy maker Orchard Therapeutics sells to Kyowa Kirin for $387M cash as lead program awaits 2024 FDA verdict (Endpoints)
• BMS-backed liquid biopsy biotech Precede Biosciences debuts to enhance precision medicine approaches (Endpoints)
• EQRx had limited buyer interest, tried acquiring other companies before Revolution came for its cash (Endpoints)
• With key Mounjaro decision ahead, Eli Lilly shuffles its C-Suite deck (Fierce Pharma)
• Public wants pharma to reveal carbon footprint of drugs (Pharmaphorum)

• Why Andreessen Horowitz's Julie Yoo sees AI as a 'leapfrog opportunity' for healthcare (Endpoints)
• Health tech startup Atropos reveals generative AI tool for parsing patient records (Endpoints)
• Medtronic posts warning after stolen, defective intubation devices advertised for sale (MedTech Dive)
• Medtronic Hires New Neuromodulation Leader (MedTech Insight)
• Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies (MedTech Insight)
• Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators (MedTech Insight)

• FDA cites Fresenius Kabi for contamination problems that CDC linked to deadly sepsis cases (STAT)
• Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases (FDA Law Blog)
• FDA calls for treatments for meth and cocaine addiction (STAT)
• Slew of pharma industry players form coalition to push back against antitrust reform (Endpoints)